Abstract: Providers' practice behaviors before and after physician and staff training in the use of a schizophrenia medication algorithm and the effects of education on physician adherence to the algorithm were evaluated.
T reatment guidelines and algorithms are increasingly used in many fields of clinical practice. The rationale for using algorithms is manifold and includes improving the quality of treatment by reducing unnecessary variations in clinical practice, improving the quality of diagnostic reasoning by making explicit clinical decisions, providing a standard to rate patient progress, providing a rational basis for when and where to introduce new medications and tests, 1 allowing for a smoother continuum of care by documenting all elements of therapy provided, 2 and enabling evaluations of physician practices through drug utilization reviews and quality improvement. 3 A well-designed and implemented algorithm can provide both administrative and health-related benefits. Using resources more efficiently by eliminating unnecessary procedures and enhancing appropriate interventions should improve the cost-effectiveness of treatment as more people will receive greater health benefit. Also, by reducing variations in practice, algorithms should help organizations and of 359 progress notes were written using the recommended documentation form. The number of progress notes containing no documentation of symptoms decreased from 66 to 41, and those documenting three to five target symptoms increased from 74 to 140. Documentation of physician assessment of the presence or absence of adverse effects and their severity decreased from 35.2% to 18.7% and from 22.3% to 17.0%, respectively. Physicians increased the documentation of their clinical global impressions from 12.1% to 20.3%. The recording of medication changes increased twofold, but the difference was not significant.
Physician and staff education alone did not significantly alter providers' practice behavior. Inadequate and inconsistent documentation of clinical outcomes made it difficult to assess physician adherence to the treatment algorithm.
tial health-related benefits include enhanced quality of care and functioning, reduced emergency services and secondary complications, and fewer encounters with the criminal justice system, particularly for those with psychiatric disorders. 2 Providing more effective treatment earlier may actually improve the cost-effectiveness of care over the course of an illness. This is particularly true when examining disease management models for chronic diseases. 5 Treatment variations and health care costs are concerns in many areas of medicine, including psychiatry. In recent years, there has been significant growth in the number of medications used for the treatment of mental illness. These medications differ in their mechanisms of action, adverse effects, safety profile, and spectrum of action. 4 In 1995, the Texas Department of Mental Health and Mental Retardation (TDMHMR) and its public academic consortium began developing medication treatment algorithms for patients with schizophrenia, bipolar disorder, and major depressive disorder-known as the Texas Medication Algorithm Project (TMAP). 1 The goals of TMAP were to improve the clinical outcomes of individuals with these disorders and improve the costeffectiveness of their care. It was also hoped that the documentation of cost-effectiveness would serve as the basis for increased legislative appropriations for public mental health care. Once the algorithms were developed, the implementation of, adherence to, and clinical and economic impact of the algorithm were evaluated. 1 Few evaluations on the efficacy of algorithms and guidelines are available, 6 and TMAP is the first evaluation of psychiatric medication algorithms for their clinical utility and cost-effectiveness. Increasingly complex treatment, exacerbated by incomplete documentation of clinical data, makes it difficult to assess clinician adherence to algorithms. To evaluate widespread adherence to algorithms, TMAP assessed the algorithm elements at critical decision points. Preliminary analyses of results indicate that TMAP improves patient mental health outcomes, but cost-effectiveness results are currently not available. [7] [8] [9] [10] [11] Once TMAP was adopted as the usual clinical care (i.e., Texas Implementation of Medication Algorithms, or TIMA), implementation issues arose. TIMA was integrated into the Texas public mental health system without the additional resources (i.e., clinical coordinators in the practice setting to assist the psychiatrist in delivering the care and implementing the algorithms, centralized technical support) that were used in TMAP. At the time of this study, the major initial implementation strategies for TIMA were staff education, a statewide request for uniform documentation, and voluntary technical assistance conference calls. It is important to know how successful these efforts were in achieving algorithm implementation. This study evaluated providers' practice behaviors before and after physician and staff education was completed at a TDMHMR state hospital and the effects of staff education on implementing a schizophrenia medication algorithm.
Methods
Study population. Patients were included in the study if they were 18 to 64 years of age and were admitted to Austin State Hospital (ASH) with a primary diagnosis of schizophrenia. ASH is a 317-bed regional state mental hospital with a funded average daily census for 276 patients. It provides both acute and long-term inpatient psychiatric services for individuals receiving care in the Texas public mental health system. Data were collected from existing medical records at ASH. The study proposal was approved by the institutional review boards at The University of Texas at Austin and at ASH. Data sources. The medical records of 30 patients admitted between September 1 and November 30, 1999, and 30 patients admitted from September 1 to November 30, 2000, with an admitting and discharge diagnosis of schizophrenia and a minimum length of 14 days were randomly selected and analyzed. These dates were chosen based on the time of the training, July 18-19, 2000, which allowed for postintervention assessments to begin about two months after the intervention (i.e., dissemination of the schizophrenia algorithm and staff education). No major algorithm changes were made during that one-year period. The sample size of 30 patients was based on the typical size of the hospital's monthly drug-use evaluations and a minimum of two weeks hospitalization, which was required to allow for adequate longitudinal evaluation of adherence to the treatment algorithm.
Patient-specific data without any patient-identifying information were transcribed from the medical record to the research record forms. Demographic and clinical information was collected from patients' medical records. Demographic information included age, sex, ethnicity, and diagnosis. Clinical data were collected from physician medication orders, physician progress notes, the Clinical Inpatient Record Progress Note, and physician discharge summaries. Specifically, the clinical data of interest included prescribed psychotropic medications and dosages, documentation of target symptoms and severity, adverse drug effects, appropriate clinical ratings, patient's response to treatment, and reason for medication change. These data were compared with the recommendations made in the schizophrenia medication algorithm. 12, 13 A schematic detailing of the algorithm appears in Figure 1 , while Figure 2 lists the "algorithm-at-a-glance" recommendations. The TIMA divides pharma-cotherapeutic approaches into different stages, and the TIMA user's manual relies largely on knowing the patient's stage of treatment. Stages are the specific treatment regimen options recommended in the algorithm.
Algorithm implementation. Efforts to implement the schizophrenia medication algorithm were primarily limited to six to eight hours of physician and other staff education regarding the TIMA philosophy, a review of the algorithm and the algorithm user's manual, videotape training on the use of brief positive and negative symptom assessments, and uniform documentation. The user's manual contains detailed information about algorithm strategies, treatment tactics, dosing, assessment of symptoms and adverse effects, and treatment of adverse effects and associated symptoms. The medical staff were asked to implement the Clinical Inpatient Record Progress Note (a uniform documentation form approved by the TDMHMR Statewide Medical Records Committee) instead of the traditional progress note. Unlike the traditional handwritten progress note, this form incorporates checklists and questions to prompt physicians to detailed information regard- 
Acute Exacerbation
First presentation or not nonresponder to olanzapine, quetiapine, or risperidone ing symptom severity, adverse effects and their severity, physician global assessments of clinical improvement, and medications prescribed, among other key information. The form was expected to reinforce the TIMA and assist physicians in consistently and explicitly recording their thought processes at critical decision points. Hospital staff also received a separate four to six hours of training on the patient family education program. Training was presented by original TMAP investigators and the TDMHMR state medical director.
Voluntary twice-monthly teleconferences were also available to assist physicians and other staff with any algorithm implementation issues. Data analyses. Patient data were statistically evaluated before and after dissemination of the algorithm. The a priori level of significance was set at 0.05. Patient demographics were described using descriptive statistics. The difference in length of hospital stay between the two groups was analyzed as a continuous vari- Response: Stages 1-4, positive symptoms score less than or equal to 6. Negative symptom score less than or equal to 12. See manual for Stages 5, 5a, and 6 and discussion of partial response.
Criteria for Medication Change: Persistent positive or negative symptoms or unacceptable side effects (see manual for discussion).
Evaluations:
At each visit an MD assessment of core symptom severity, overall functional impairment, other symptoms. Algorithm Coordinator assessment using brief positive and negative scales and patient global self-rating of symptom severity and side effects. able using the two-tailed Student's t test. Differences between the groups for various measures (e.g., target symptom identification and severity, adverse effect identification and severity, clinical ratings, and medication changes) were evaluated using the chi-square test. Target symptoms of schizophrenia were divided into two categories: positive symptoms (i.e., suspiciousness, unusual thought content, hallucinations, and conceptual disorganization) and negative symptoms (i.e., reduced emotional expression, reduced social drive, poor grooming and hygiene, and prolonged response time).
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Results
Patients' medical records were reviewed, and data were collected using forms that contained content similar to that found in the Clinical Inpatient Record Progress Note. A total of 60 patient charts were reviewed-30 each from the prealgorithm and postalgorithm implementation groups. The mean ± S.D. age of patients was 41 ± 11.2 years and 38.6 ± 11.5 years in the intervention and control groups, respectively. A majority of the patients were men, and most were either Caucasian or AfricanAmerican (Table 1 ). The average length of hospital stay was 37.6 ± 18.7 days in the intervention group and 33 ± 17.5 days in the control group. Patient demographics and length of stay did not differ significantly between the groups (Table 1) .
Physicians wrote 56 progress notes per week (or 1.9 notes/patient/ wk) in the prealgorithm group and 66.8 progress notes per week (or 2.2 notes/patient/wk) in the postalgorithm group. Of the 359 progress notes written after physicians received algorithm training, only 5 were written using the recommended Clinical Inpatient Record Progress Note. Symptom data collected included physician documentation of four positive and four negative symptoms and the severity of patients' symptoms. Documentation of the presence or absence of unusual thought content, emotional expression, and grooming and hygiene significantly increased after physicians were trained in using the algorithm ( Table 2) . Documentation of the severity of these three symptoms also increased. However, documentation of patients' severity of suspiciousness declined (Table 3) . No progress notes from either group documented the scores of the algorithm-recommended brief positive and negative symptoms rating scales.
Categories of symptom documentation were also evaluated, and the number of symptoms documented increased after training (χ 2 = 25.0, d.f. = 3, p < 0.001). The number of progress notes containing no documentation of symptoms decreased from 66 (25%) to 41 (11.4%), and the number of progress notes documenting three to five target symptoms increased from 74 (28%) to 140 (39%). The percentage of progress notes with one or two documented Am J Health-Syst Pharm-Vol 60 Jul 15, 2003 symptoms increased from 45.5% (120 of 264) to 49.3% (177 of 359), whereas the number of notes with six to eight symptoms documented decreased from 4 to 1 ( Table 2) .
Documentation of other symptoms (e.g., insomnia, mania, depression, irritability, agitation, mood lability, appetite, and energy level) did not significantly differ between groups. Progress note documentation of physician assessment of the presence or absence of adverse effects and their severity decreased from 35.2% (93) Medical records were also analyzed for the presence of a progress note on the day of a medication change. On the days of a medication change, 32 of 41 progress notes were written in the prealgorithm group and 33 of 49 were written in the postalgorithm group. The reason for the medication change was noted in 7 (21.9%) of 32 progress notes in the prealgorithm group and 14 (42.4%) of 33 progress notes in the postalgorithm group. Although the documentation of reasons for medication changes increased by twofold after the implementation of the algorithm, the difference was not significant.
Approximately 80% of all patients studied received usual dosages of antipsychotic medications, and about 14% of patients received dosages greater than the maximum stated in the product labeling. No significant differences were found between groups.
Since physicians rarely stated patients' stage in the algorithm and the medical records did not show all past medications prescribed for patients, it was not possible to accurately characterize the patients' particular stage in the algorithm. Therefore, medication steps were utilized. A medication step is a prescribed medication As defined in the algorithm, 4 and 12 weeks were the minimum and maximum limits, respectively, for an acceptable medication treatment trial (i.e., a specific step). That is, patients should be treated with a particular antipsychotic for a minimum of 4 weeks (in the absence of adverse effects) before changing due to lack of symptom improvement, and treatment on a particular regimen (except clozapine) should not continue beyond 12 weeks in the presence of significant psychotic symptoms. 12, 13 There were no significant differences between the two groups with respect to the number of medication changes within four weeks (9 [22.5%] versus 12 [27.3%]). The reasons for changing medications within 4 weeks of the initial order were not documented in any record. The percentage of patients who were switched to an appropriate second medication because of minimal improvement could not be analyzed because reasons for medication changes were often not documented. No patients were treated for more than 12 weeks with a single step of a medication regimen, because of patient discharge or a change in medication (due to lack of symptom improvement).
The number of medication steps used and the mean number of days in each step were analyzed. The number of medication steps did not change with the addition of algorithm training: one medication step used (21 patients in each group), two steps used (5 patients in each group), three steps used (4 in preintervention group versus 2 in postintervention group), and four steps used (2 in the postintervention group). There were no significant differences between the two groups with respect to the frequency and types of antipsychotic polypharmacy (e.g., atypical plus typical antipsychotic, atypical plus typical decanoate antipsychotic). In the prealgorithm group, all cases of antipsychotic polypharmacy consisted of two antipsychotics. In the postalgorithm group, two cases of polypharmacy involved three antipsychoticsan atypical antipsychotic plus an oral and decanoate preparation of a typical antipsychotic. Discharge medications did not differ between groups.
Discussion
After the schizophrenia treatment algorithm was disseminated, physician documentation changed in some areas, but no overall major changes were observed. Although the rate of documentation of the presence or absence of target symptoms increased, it was still low. In the postalgorithm group, improved documentation was observed for only one positive symptom (i.e., unusual thought content). As for the negative symptoms, emotional expression was the most documented symptom at 37%, while the remaining symptoms were documented less than 20% of the time.
While these results are discouraging, they are similar to the results of other studies that rely on education alone to implement guidelines. However, few studies have focused on education as the only intervention, and very few have actually measured outcomes. 15 In psychiatric practice, placing patients in the appropriate algorithm stage can be inherently difficult because clinical histories gathered from patients and documentation of patient medication histories may not be reliable. Patients with severe mental illnesses may be experiencing symptoms or cognitive dysfunction that limit their ability to report past treatment responses, and they may not have well-informed or available caregivers. 16 Despite these obstacles, appropriate documentation should be a priority, since it is essential for determining patient outcomes and the effectiveness of pharmacotherapy. Lack of consistent documentation decreased our ability to determine physician adherence to the algorithm. First, there was no documentation of patients' initial algorithm stage; therefore, several objectives (i.e., time spent in a particular treatment stage without improvement and percentage of patients moved to the next appropriate stage in the algorithm) could not be accurately evaluated. Second, physicians' intentions and reasons for maintaining or changing medications could not be readily inferred. For example, in patients that were discharged on both oral haloperidol and haloperidol decanoate, it is difficult to discern whether the physician's intent was for the oral haloperidol to be discontinued in the future or if the patient was to remain on both forms indefinitely. This lack of information in the discharge summary makes it difficult for the outpatient-treating clinician to know the goals of treatment.
Incomplete documentation of clinical data obscures the identification of errors regarding algorithmrecommended strategies, which, along with the complexity of some algorithms, confounds the evaluation of clinician adherence. 2 Accomplishing the goal of improving the quality of patient care through evidence-based practices includes monitoring clinician adherence to guidelines and providing feedback. Therefore, successful interventions should employ systems that provide information on performance and outcomes that are related to the behavioral change. Goldberg et al.
14 conducted a randomized controlled trial to determine the effectiveness of academic detailing and continuous quality improvement (CQI) teams in increasing compliance with national guidelines for treating hypertension and depression. Members of the CQI teams were given handbooks on how to improve quality using team-based approaches but were not provided with documentation forms or instructions on what data to collect when making and monitoring changes recommended by the algorithms. Not surprisingly, they found real-time collection of data difficult. The ineffectiveness of both the academic detailing and CQI teams in that study reinforces the idea that enabling methods, such as documentation forms, are needed to facilitate the recording of physician interventions in order to review the data used in the decision-making process. In the study presented here, the Clinical Inpatient Record Progress Note, a core component of the algorithm program, was not used. This was true despite the fact that the form had been approved by the statewide medical records committee and its use was strongly encouraged by the state medical director during onsite training.
Bettinger et al. 17 assessed physician adherence to the TIMA for major depressive disorders in two Texas community mental health centers. Patient outcome measures and requested documentation were similar to the present study and included a symptoms rating scale, severity of symptoms and adverse effects, and the clinician's global impression. The notable difference in implementation procedures was that the medical staff had incorporated a uniform clinical report form as a component of usual care. Since their physicians utilized a uniform chart documentation form, a set of "rules" could be used to calculate adherence. Although documentation was inconsistent for all outcome measures, the form was used for all patients. Clinician adherence to the algorithm was relatively high, with overall adherence rates in the 70% range, with the exception of one physician who demonstrated very low adherence. This particular physician was hired after the medical staff had received training in the algorithm and the documentation process. These preliminary findings suggest that a medication algorithm can be implemented in the public mental health sector and that the use of a uniform documentation form is a key component of implementation.
Dennehy et al. 18 evaluated physician adherence to TMAP's algorithms for bipolar disorder. This analysis examined algorithm adherence during the actual TMAP comparative evaluation study, 10 thus implementation was much more intensive (e.g., clinical coordinator, ongoing technical support and feedback) than in either of the TIMA real-life studies. Standardized clinical record forms and computerized objective rules were used to evaluate adherence. Although adherence rates over one year of outpatient care for the various domains of practice behavior were generally high, they were still variable, with the greatest adherence (97%) in using algorithm-recommended medications and the least (55%) in scheduling visits for a symptomatic patient. The authors stated that medication dosing within the recommended range was the strongest adherence variable and suggested that clinical record forms and computerized rules are a valid measure of adherence to the bipolar disorder algorithm. Furthermore, their preliminary conclusion was that adherence predicts clinical outcomes with about 44% accuracy. One might expect that the longer study duration, one year in the Dennehy et al. study and eight months in the Bettinger et al. study, would actually lead to lower adherence rates compared with this short-term study.
In addition to providing better health care services, implementing evidence-based practices can be a means of achieving accountability for decisions made. 19 Recent research has emphasized using formal assessment tools that quantitatively monitor fidelity with an implemented treatment model. 20, 21 This suggests that the use of traditional progress notes cannot accurately assess clinicians' adherence and fidelity to a treatment model.
The results of this study show that education alone is not effective in changing physician behavior and that psychiatrist documentation with traditional progress notes provides an inadequate description of patient care and outcomes. Furthermore, the inadequate and inconsistent documentation makes it difficult to assess true adherence to the algorithm.
Research indicates that, in mental health programs, the quality of implementation appears directly related to practice changes and outcomes. 21 Rubenstein et al. 22 focused on a collaborative approach to the treatment of depression in managed care settings. Primary care expert leaders hired depression nurse specialists, who attended a one-day training session, and psychotherapists, who spent at least two days in training. Both written and videotaped study materials were utilized, and detailed tracking materials for proper patient follow-up were provided to the psychotherapists. Guideline adherence rates for most interventions were above 70% and many were near 100%. When the educational efforts were focused on local primary care providers, adherence rates were 80% with lectures and seminars and 48% with academic detailing. These findings confirmed the idea that multifaceted educational interventions may be more successful than single interventions. 15 In another study, collaborative patient management by the primary care physician and a consulting psychiatrist, intensive patient education, and the monitoring of continued medication refills improved patient adherence to antidepressant regimens. 5 Also, patient satisfaction and clinical outcomes improved in those with major depression. The investigators also noted that behavioral changes did not endure after the intervention was withdrawn and that ongoing interventions to make care consistent with treatment guidelines are likely needed.
Experts in organizational behavior argue that an emphasis must be placed on changing the organization if effective implementation of a new intervention is to occur in a practice setting. 20 This is emphasized in the Institute of Medicine's report on improving the quality of health care in the United States, which states that the primary problems with health care in the United States lie with dysfunctional organizations and systems of care and not with inadequate providers. 23 It outlines simple rules and challenges for improving the quality of care and states that organizations must make implementing evidencebased practices a priority in care. To accomplish this, the quality of communications must improve among health care providers and between providers and patients. We must also improve our applications of computer technology in documenting patient care processes, monitoring and evaluating care, and establishing efficient communications. Furthermore, the health care industry must become more serious about continuous quality management as a routine practice to enhance the quality of care provided.
A treatment algorithm is a product and in itself does nothing. A plan for implementation and organizational change must be created that provides a mechanism for the treatment algorithm to actually be implemented within the organization. Along with implementation, a system of accountability must be established that holds both the organization and the providers accountable for implementation of the algorithm. Rosenheck 20 regards this measure of accountability as fidelity and states that measures of fidelity of care must be examined at both the provider and the organizational levels. He states that champions for the implementation process must be present within the organization, and they must involve all stakeholders in ensuring that implementation occurs. These champions must assist members of the organization in recognizing that the product and processes to be implemented are consistent with the organization's values or goals (e.g., improving the quality of care). Finally, the new product and processes must eventually become part of the subculture of the organization to be successful in the long-term.
As TDMHMR has learned from its algorithm implementation attempts, it is seeking to apply these principles to application. Collaboration with organizational behavior experts has occurred and planning has begun for the development and implementation of a framework for change. Instruments are being created to assess fidelity to the algorithm at both the organizational and provider levels. Perhaps by applying these principles to algorithm implementation, future studies will show that the degree of adherence has increased.
Conclusion
Physician and staff education alone did not significantly alter providers' practice behaviors. Inadequate and inconsistent documentation of clinical outcomes made it difficult to assess physician adherence to the treatment algorithm.
